MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide effective treatment of pain and tissue damage in the rehabilitation market. It also provides DermSecure, a telemedicine software application. In addition, the company offers MedX rehab console system, rehab portable laser, and home unit; OraLase, a dental PBM laser; and veterinary-specific lasers. MedX Health Corp was incorporated in 1999 and is headquartered in Mississauga, Canada.…
MedX Health Appoints Monaderm as a Representative for SkinSecure™ Across Europe for Beauty and Aesthetics Research
MedX Health Corp (CVE: MDX) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Medical Devices industry, part of the Healthcare sector.
The shares were at 0.0500 CAD on 19 November 2026, down 28.6% over 52 weeks. Its 52-week range is 0.0400 CAD to 0.0700 CAD: the price is 28.6% below the high and 25.0% above the low.
Its market capitalisation is 16.40M CAD.
MedX Health Corp reports return on equity of 64.6% and revenue up 33.7% year over year.
Its debt exceeds its cash by 8.67M CAD. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health. The next earnings report is expected on 1 December 2026.